已收录 267400 条政策

政策提纲

A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese Patients With Metastatic Colorectal Cancer (BIX Study)

[摘要]

[发布日期] [发布机构]

[效力级别] [学科分类] 肿瘤学

[关键词] [时效性]

浏览次数：2